LANTERN PHARMA INC
LTRN·51654W101·US·Common Stock·Healthcare - Biotechnology-Activist
LTRN (LANTERN PHARMA INC) is held by 28 institutional investors as of Q2 2026. Largest holders: VANGUARD CAPITAL MANAGEMENT LLC ($1.8M), RENAISSANCE TECHNOLOGIES LLC ($1.2M), GEODE CAPITAL MANAGEMENT, LLC ($428,852). Net institutional sentiment: Mixed.
28
Holders
(1 Elite)
$5.2M
Total Value
61% (23)
Consensus
14 buying - 9 selling
13F: Insider & Congress: Updated regularly
Who's Trading
Source dates: Price Oct 13, 2026 · Insiders May 14, 2026 · Activists Oct 13, 2026 · Congress none
ActivistEAEmpery Asset Management, LP5.0%Oct 13, 2026
ActivistEAEmpery Asset Management, LP10.0%Aug 4, 2026
ActivistTAThomas A. Satterfield, Jr.7.6%Jul 23, 2026
Checking access…
Top Holders
Checking access…
Showing 1-20 of 32
1 / 2
Continue exploring
Other Healthcare stocks held by institutions
417 holders · $300.5B
416 holders · $881.6B
401 holders · $151.5B
398 holders · $415.6B
395 holders · $98.9B
394 holders · $111.8B
391 holders · $230.3B
386 holders · $303.9B
386 holders · $52.4B
383 holders · $114.2B
Data sourced from four public-disclosure sources: SEC 13F, Form 4, 13D/13G, and House/Senate STOCK Act disclosures. Not financial advice. Full disclaimer